Patent · US Active

Compositions containing LAG-3 and cells that secrete GM-CSF and methods of use

US8425897B2 · kind B2 · utility

5Cited by
21References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 29, 2008
Grant dateApr 23, 2013
Priority date
Expiry dateJul 26, 2029

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K2039/55522
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates to a method of enhancing anti-tumor protection in a mammal. More particularly, the invention is concerned with combinations comprising antigen presenting cell (APC) activators and a cytokine-secreting cell and methods of administering the combination for enhanced immune response to tumor cells in a patient with a cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.